MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)
source: myfinsight.com
Download
Download image
Net loss and
comprehensive loss
-$30,369K
(67.80%↑ Y/Y)
Product revenue, net
$58,301K
(104.43%↑ Y/Y)
Loss from operations
-$15,477K
(80.37%↑ Y/Y)
Total other expense
-$14,892K
(3.63%↑ Y/Y)
Gross profit
$46,305K
(86.75%↑ Y/Y)
Interest income
$1,736K
(-34.24%↓ Y/Y)
Cost of revenue
$11,996K
(222.13%↑ Y/Y)
Total operating
expenses
$61,782K
(-40.40%↓ Y/Y)
Interest expense
$15,797K
(-12.58%↓ Y/Y)
Other expense, net
-$831K
(-3677.27%↓ Y/Y)
Selling, general and
administrative
$54,011K
(-42.83%↓ Y/Y)
Research and development
$7,771K
(-15.39%↓ Y/Y)
Back